These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 18715693)

  • 21. Utility of a modality combining FISH and cytology in upper tract urothelial carcinoma detection in voided urine samples of Chinese patients.
    Xu C; Zeng Q; Hou J; Gao L; Zhang Z; Xu W; Yang B; Sun Y
    Urology; 2011 Mar; 77(3):636-41. PubMed ID: 21256577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging.
    Painter DJ; Timoney AG; Denton K; Alken P; Keeley FX
    BJU Int; 2007 May; 99(5):973-7. PubMed ID: 17437428
    [No Abstract]   [Full Text] [Related]  

  • 23. Lynch Syndrome: A Primer for Urologists and Panel Recommendations.
    Mork M; Hubosky SG; Rouprêt M; Margulis V; Raman J; Lotan Y; O'Brien T; You N; Shariat SF; Matin SF
    J Urol; 2015 Jul; 194(1):21-9. PubMed ID: 25711197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic features of urothelial carcinoma of the bladder and the upper urinary tract].
    Cussenot O; Davin JL
    Prog Urol; 2003 Nov; 13(5 Suppl 2):1233. PubMed ID: 15816391
    [No Abstract]   [Full Text] [Related]  

  • 25. Upper Urinary Tract Urothelial Carcinoma in Lynch Syndrome Patients: The Urologist Still Has a Role in Genetic Screening.
    Grobet-Jeandin E; Pinar U; Rouprêt M
    Eur Urol Oncol; 2022 Feb; 5(1):42-43. PubMed ID: 34980573
    [No Abstract]   [Full Text] [Related]  

  • 26. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
    Gupta R; Paner GP; Amin MB
    Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poorly differentiated transitional cell carcinoma versus leiomyosarcoma of the ureter: different defects in tumour suppressor genes.
    Tzen CY; Wu CJ; Huang ZD; Wu TY
    Histopathology; 2007 Aug; 51(2):271-3. PubMed ID: 17593211
    [No Abstract]   [Full Text] [Related]  

  • 28. [Analysis of the microsatellite instability gene mutation in the urothelial tumor of the upper urinary tract].
    Mongiat-Artus P; Miquel C; van der Aa M; Buhard O; Hamelin R; Soliman H; Bangma C; Janin A; Teillac P; van der Kwast T; Praz F
    Prog Urol; 2005 Dec; 15(6 Suppl 1):1286-92. PubMed ID: 16734218
    [No Abstract]   [Full Text] [Related]  

  • 29. Familial transitional cell carcinoma and the Lynch syndrome II.
    Greenland JE; Weston PM; Wallace DM
    Br J Urol; 1993 Aug; 72(2):177-80. PubMed ID: 8402022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Lynch syndrome II and urological malignancies.
    Lynch HT; Ens JA; Lynch JF
    J Urol; 1990 Jan; 143(1):24-8. PubMed ID: 2294255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor variation in three extended Lynch syndrome II kindreds.
    Lynch HT; Ens J; Lynch JF; Watson P
    Am J Gastroenterol; 1988 Jul; 83(7):741-7. PubMed ID: 3381806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular subtype classification of urothelial carcinoma in Lynch syndrome.
    Therkildsen C; Eriksson P; Höglund M; Jönsson M; Sjödahl G; Nilbert M; Liedberg F
    Mol Oncol; 2018 Aug; 12(8):1286-1295. PubMed ID: 29791078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas.
    Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
    J Urol; 2005 Jan; 173(1):243-6. PubMed ID: 15592089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.
    Petros FG; Choi W; Qi Y; Moss T; Li R; Su X; Guo CC; Czerniak B; Dinney C; McConkey DJ; Matin SF
    J Urol; 2021 Sep; 206(3):548-557. PubMed ID: 33881933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current criteria for the diagnosis and treatment of transitional cell carcinomas of the upper urinary tract].
    Rodríguez Vela L; Rioja Sanz C; Caro Cebrían C; González Enguita C; Rioja Sanz LA
    Arch Esp Urol; 1988 Jun; 41(5):349-61. PubMed ID: 3056285
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiple primary cancer, including transitional cell carcinoma of the upper uroepithelial tract in a multigeneration HNPCC family: molecular genetic, diagnostic, and management implications.
    Lynch HT; Taylor RJ; Lynch JF; Knezetic JA; Barrows A; Fodde R; Wijnen J; Wagner A
    Am J Gastroenterol; 2003 Mar; 98(3):664-70. PubMed ID: 12650804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic algorithm of urothelial tumor of the upper urinary tract].
    Höltl W
    Urologe A; 2001 Nov; 40(6):451. PubMed ID: 11760348
    [No Abstract]   [Full Text] [Related]  

  • 38. Variable gastrointestinal and urologic cancers in a Lynch syndrome II kindred.
    Lynch HT; Richardson JD; Amin M; Lynch JF; Cavalieri RJ; Bronson E; Fusaro RM
    Dis Colon Rectum; 1991 Oct; 34(10):891-5. PubMed ID: 1914723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digging through a genomic goldmine: defining the optimum upper urinary tract surveillance strategy for Lynch syndrome.
    Khan-Ruf S; Thurairajah R; Khan MS; Bultitude M; Thomas K; Nair R
    BJU Int; 2020 Jan; 125(1):6-7. PubMed ID: 31410956
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hereditary nonpolyposis colorectal cancer (Lynch syndrome). Clinical case].
    Torres-Machorro A; Aragón-Anzures A; Barrera-Pérez M; Chávez-Tapia NC; Valdovinos MA
    Rev Gastroenterol Mex; 2006; 71(3):312-5. PubMed ID: 17140054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.